Résumé :
|
[BDSP. Notice produite par INIST-CNRS mER0x9A8. Diffusion soumise à autorisation]. Results from epidemiologic studies examining pancreatic cancer risk and vitamin D intake or 25-hydroxyvitamin D (25 (OH) D) concentrations (the best indicator of vitamin D derived from diet and sun) have been inconsistent. Therefore, the authors conducted a pooled nested case-control study of participants from 8 cohorts within the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers (VDPP) (1974-2006) to evaluate whether pre-diagnostic circulating 25 (OH) D concentrations were associated with the development of pancreatic cancer. In total, 952 incident pancreatic adenocarcinoma cases occurred among participants (median follow-up, 6.5 years). Controls (n=1,333) were matched to each case by cohort, age, sex, race/ethnicity, date of blood draw, and follow-up time. Conditional logistic regression analysis was used to calculate smoking-body mass index-and diabetes-adjusted odds ratios and 95% confidence intervals for pancreatic cancer. Clinically relevant 25 (OH) D cutpoints were compared with a referent category of 50-<75 nmol/L. No significant associations were observed for participants with lower 25 (OH) D status. However, a high 25 (OH) D concentration (>=100 nmol/L) was associated with a statistically significant 2-fold increase in pancreatic cancer risk overall (odds ratio=2.12,95% confidence interval : 1.23,3.64). Given this result, recommendations to increase vitamin D concentrations in healthy persons for the prevention of cancer should be carefully considered.
|